相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Examination of burden of skeletal-related events in patients naive to denosumab and intravenous bisphosphonate therapy in bone metastases from solid tumors population
Debajyoti Bhowmik et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma
Siyang Leng et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data
Christopher Kim et al.
JOURNAL OF BONE ONCOLOGY (2019)
Utilization of agents to prevent skeletal-related events among patients with multiple myeloma: analysis of real-world data
Yi Qian et al.
SUPPORTIVE CARE IN CANCER (2018)
Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study
John Ashcroft et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma
Andrew J. Yee et al.
FUTURE ONCOLOGY (2018)
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update
Kenneth Anderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
Noopur Raje et al.
LANCET ONCOLOGY (2018)
Biology and treatment of myeloma related bone disease
Evangelos Terpos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Patterns of bisphosphonate treatment among patients with multiple myeloma treated at oncology clinics across the USA: observations from real-world data
Christopher Kim et al.
SUPPORTIVE CARE IN CANCER (2018)
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Evangelos Terpos et al.
BLOOD CANCER JOURNAL (2018)
Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database
Debajyoti Bhowmik et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey
T. Lebret et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes
O. Landgren et al.
JOURNAL OF INTERNAL MEDICINE (2017)
PATIENT CHARACTERISTICS, SKELETAL RELATED EVENTS (SRE) AND RENAL IMPAIRMENT (RI) IN PATIENTS WITH MULTIPLE MYELOMA (MM): A PATIENT CHART AUDIT IN EU5
M. Mateos et al.
VALUE IN HEALTH (2017)
Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States
Yi Qian et al.
CANCER MEDICINE (2017)
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. Moreau et al.
ANNALS OF ONCOLOGY (2017)
Multiple myeloma: patient outcomes in real-world practice
Kwee Yong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients
Maja Hinge et al.
HAEMATOLOGICA (2016)
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Meletios A. Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Novel agents in the treatment of multiple myeloma: a review about the future
Leonard Naymagon et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients
Maja Hinge et al.
HAEMATOLOGICA (2016)
Frequency of skeletal-related events and associated healthcare resource use and costs in US patients with multiple myeloma
Emily Nash Smyth et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Health resource utilization associated with skeletal-related events: results from a retrospective European study
Jean-Jacques Body et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Evangelos Terpos et al.
HAEMATOLOGICA (2015)
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
W. I. Gonsalves et al.
BLOOD CANCER JOURNAL (2015)
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Evangelos Terpos et al.
HAEMATOLOGICA (2015)
Bone health in cancer patients: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study
Karin Jordan et al.
SUPPORTIVE CARE IN CANCER (2014)
Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countries
H. Hoefeler et al.
JOURNAL OF BONE ONCOLOGY (2014)
International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease
Evangelos Terpos et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Skeletal-Related Events In Myeloma: A Population-Based Study
John Ashcroft et al.
BLOOD (2013)
Myeloma bone disease: Pathophysiology and management
Rebecca Silbermann et al.
JOURNAL OF BONE ONCOLOGY (2013)
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
Gareth J. Morgan et al.
LANCET ONCOLOGY (2011)
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
Meletios A. Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease
E. Terpos et al.
LEUKEMIA (2010)
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
M. Dimopoulos et al.
LEUKEMIA (2009)
Pathologic fractures correlate with reduced survival in patients with malignant bone disease
Fred Saad et al.
CANCER (2007)
Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party
BM Augustson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes
F Wisloff et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
分享论文
